Herein, we aim to describe the structure and the known ligands of LAG-3 and summarize the immune-regulatory effects on active T cells in tumor microenvironment, as well as the LAG-3 inhibitors which have been evaluated in the clinic. The gene discussed is LAG3; the disease is neoplasm.